Showing results (191-200 of 498) with videos related to
Sort By:
Pageof 50
Acta Dermatovenerologica Croatica : ADC|September 6, 2017
Mast Cell Disorders, Melanoma and Pancreatic Carcinoma: From a Clinical Observation to a Brief Review of the LiteratureGiovanni Paolino, Maria Belmonte, Stefania Trasarti, et al.British Journal of Haematology|May 1, 2021
The current role of interferon in hairy cell leukaemia: clinical and molecular aspectsGiovanni M Assanto, Costantino Riemma, Francesco Malaspina, et al.Leukemia & Lymphoma|April 19, 2019
Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patientsMaria Luisa Moleti, Mazin Faisal Al-Jadiry, Wafa Ablahad Shateh, et al.Cancer Medicine|March 11, 2020
Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paperSimona Soverini, Francesco Albano, Renato Bassan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility studyCorrado Girmenia, Alessandra Micozzi, Giuseppe Gentile, et al.British Journal of Haematology|October 20, 2018
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinibAnna Guarini, Nadia Peragine, Monica Messina, et al.Acta Haematologica|September 15, 2020
COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in RomeCorrado Girmenia, Giuseppe Gentile, Alessandra Micozzi, et al.Haematologica|June 1, 2005
TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAILRoberta Riccioni, Luca Pasquini, Gualtiero Mariani, et al.Leukemia & Lymphoma|March 7, 2014
NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatmentSabina Chiaretti, Marilisa Marinelli, Ilaria Del Giudice, et al.Leukemia Research|February 19, 2014
Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemiaCorrado Girmenia, Alessandra Micozzi, Alfonso Piciocchi, et al.Pageof 50